Edward K. Chow, Ph.D. - Publications

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chew CAZ, Tay LM, Hooi L, Chow EK, Bonney GK, Chan SL. Abstract 3929: Patient-derived pancreatic cancer organoids as in-vitro cancer models for personalizing therapy Cancer Research. 80: 3929-3929. DOI: 10.1158/1538-7445.Am2020-3929  0.304
2015 Ho D, Wang CK, Chow EK. Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine. Science Advances. 1: e1500439. PMID 26601235 DOI: 10.1126/Sciadv.1500439  0.305
2014 Toh TB, Lee DK, Hou W, Abdullah LN, Nguyen J, Ho D, Chow EK. Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells. Molecular Pharmaceutics. 11: 2683-91. PMID 24867631 DOI: 10.1021/Mp5001108  0.302
2014 Chow EK. TRAIL-Blazing Therapy Against Circulating Tumor Cells Science Translational Medicine. 6: 221ec18-221ec18. DOI: 10.1126/Scitranslmed.3008472  0.305
2013 Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clinical and Translational Medicine. 2: 3. PMID 23369605 DOI: 10.1186/2001-1326-2-3  0.302
2012 Chow EK. Implication of cancer stem cells in cancer drug development and drug delivery. Journal of Laboratory Automation. 18: 6-11. PMID 22893634 DOI: 10.1177/2211068212454739  0.311
2011 Ghaffari AA, Chow EK, Iyer SS, Deng JC, Cheng G. Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3. Hepatology (Baltimore, Md.). 53: 2042-52. PMID 21433044 DOI: 10.1002/Hep.24316  0.539
2009 Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. The Journal of Clinical Investigation. 119: 1910-20. PMID 19487810 DOI: 10.1172/Jci35412  0.719
2008 Chow EK, Pierstorff E, Cheng G, Ho D. Copolymeric nanofilm platform for controlled and localized therapeutic delivery. Acs Nano. 2: 33-40. PMID 19206545 DOI: 10.1021/Nn7000917  0.495
2007 Chow EK, Razani B, Cheng G. Innate immune system regulation of nuclear hormone receptors in metabolic diseases. Journal of Leukocyte Biology. 82: 187-95. PMID 17314330 DOI: 10.1189/Jlb.1206741  0.702
2007 CHOW EK, CHU B, CHENG G, TAI Y, PIERSTORFF E, HO D. COPOLYMER-MEDIATED FABRICATION OF VERSATILE ELECTRO-ACTIVE AND INFLAMMATION ATTENUATING SUBSTRATES FOR BIOLOGICAL INTERROGATION Nano. 2: 351-359. DOI: 10.1142/S1793292007000696  0.473
2007 Chow EK, Pierstorff E, Cheng G, Tai YC, Ho D. Attenuation of cellular inflammation using glucocorticoid-functionalized copolymers Proceedings of the 2nd Ieee International Conference On Nano/Micro Engineered and Molecular Systems, Ieee Nems 2007. 1039-1043. DOI: 10.1109/NEMS.2007.352195  0.427
2006 Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, Tontonoz P, Cheng G. A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections. The Journal of Experimental Medicine. 203: 2589-602. PMID 17074929 DOI: 10.1084/Jem.20060929  0.727
2005 Chow EK, O'connell RM, Schilling S, Wang XF, Fu XY, Cheng G. TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk. The Embo Journal. 24: 4071-81. PMID 16308570 DOI: 10.1038/Sj.Emboj.7600867  0.649
2004 Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. The Journal of Experimental Medicine. 199: 1651-8. PMID 15210743 DOI: 10.1084/Jem.20040528  0.552
2004 Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G. Toll-like receptors induce a phagocytic gene program through p38. The Journal of Experimental Medicine. 199: 81-90. PMID 14699082 DOI: 10.1084/Jem.20031237  0.741
2003 Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. Journal of Immunology (Baltimore, Md. : 1950). 170: 3565-71. PMID 12646618 DOI: 10.4049/Jimmunol.170.7.3565  0.739
Show low-probability matches.